Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and immunogenicity of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine in adults and children in Vellore, South India.
Raghava Mohan V, Raj S, Dhingra MS, Aloysia D'Cor N, Singh AP, Saluja T, Kim DR, Midde VJ, Kim Y, Vemula S, Narla SK, Sah B, Ali M. Raghava Mohan V, et al. Among authors: midde vj. PLoS One. 2019 Jun 18;14(6):e0218033. doi: 10.1371/journal.pone.0218033. eCollection 2019. PLoS One. 2019. PMID: 31211792 Free PMC article. Clinical Trial.
Antibody Persistence Following Administration of a Hexavalent DTwP-IPV-HB-PRP~T Vaccine Versus Separate DTwP-HB-PRP~T and IPV Vaccines and Safety and Immunogenicity of a Booster Dose of DTwP-IPV-HB-PRP~T Administered With an MMR Vaccine in Healthy Infants in India.
Mangarule S, Siddaiah P, Kawade A, Dhati RM, Padmavathi IV, Palkar S, Tripathi V, Singh R, Palvi K, Mitra M, Shetty R, Leclercq J, Midde VJ, Varghese K, Kandukuri SR, Kukian D, Noriega F. Mangarule S, et al. Among authors: midde vj. Pediatr Infect Dis J. 2023 Dec 1;42(12):1128-1135. doi: 10.1097/INF.0000000000004118. Epub 2023 Oct 13. Pediatr Infect Dis J. 2023. PMID: 37851978
Safety and immunogenicity of a new formulation of a pentavalent DTwP-HepB-Hib vaccine in healthy Indian infants-A randomized study.
Aloysia D'Cor N, Siddaiah P, Mohapatra S, Dhaded SM, I V P, Kar S, V N T, Muley P, Chhatwal J, Patnaik BN, Vidor E, Moureau A, Patel DM, Midde VJ, Jagga SR, Peesapati S, Noriega F. Aloysia D'Cor N, et al. Among authors: midde vj. PLoS One. 2023 Aug 15;18(8):e0284898. doi: 10.1371/journal.pone.0284898. eCollection 2023. PLoS One. 2023. PMID: 37582114 Free PMC article. Clinical Trial.
Immunogenicity and Safety of a Hexavalent DTwP-IPV-HB-PRP~T Vaccine Versus Separate DTwP-HB-PRP~T, bOPV, and IPV Vaccines Administered at 2, 4, 6 Months of Age Concomitantly With Rotavirus and Pneumococcal Conjugate Vaccines in Healthy Infants in Thailand.
Sanchez L, Rungmaitree S, Kosalaraksa P, Jantarabenjakul W, Leclercq J, Yaiprayoon Y, Midde VJ, Varghese K, Mangarule S, Noriega F. Sanchez L, et al. Among authors: midde vj. Pediatr Infect Dis J. 2023 Aug 1;42(8):711-718. doi: 10.1097/INF.0000000000003975. Epub 2023 Apr 27. Pediatr Infect Dis J. 2023. PMID: 37257121 Free PMC article. Clinical Trial.
Bivalent oral cholera vaccine in participants aged 1 year and older in the Dominican Republic: A phase III, single-arm, safety and immunogenicity trial.
Cordero De Los Santos L, Feris-Iglesias J, Aloysia D'Cor N, Midde VJ, Patnaik BN, Thollot Y, Rasuli A, Desauziers E. Cordero De Los Santos L, et al. Among authors: midde vj. Hum Vaccin Immunother. 2018 Jun 3;14(6):1403-1411. doi: 10.1080/21645515.2018.1430540. Epub 2018 Feb 22. Hum Vaccin Immunother. 2018. PMID: 29470934 Free PMC article. Clinical Trial.